Abstract
We report the first case of Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection in Japan. A 54-year-old woman developed neurological symptoms after SARS-CoV-2 infection. We tested for various antiganglioside antibodies, that had not been investigated in previous cases. The patient was diagnosed with GBS based on neurological and electrophysiological findings; no antiganglioside antibodies were detected. In previous reports, most patients with SARS-CoV-2-infection-related GBS had lower limb predominant symptoms, and antiganglioside antibody tests were negative. Our findings support the notion that non-immune abnormalities such as hyperinflammation following cytokine storms and microvascular disorders due to vascular endothelial damage may lead to neurological symptoms in patients with SARS-CoV-2 infection. Our case further highlights the need for careful diagnosis in suspected cases of GBS associated with SARS-CoV-2 infection.
Reference23 articles.
1. The Epidemiology of Guillain-Barré Syndrome Worldwide
2. Peripheral neuropathies and anti-glycolipid antibodies
3. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic;Uncini;J Neurol Neurosurg Psychiatr,2020
4. COVID-19-associated Guillain-Barré syndrome: the early pandemic experience;Caress;Muscle Nerve,2020
5. Post SARS-CoV-2 Guillain-Barré syndrome;Arnaud;Clin Neurophysiol,2020
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献